I'd wager that nearly everyone reading this letter has at some point watched a spouse, family member, or a close friend struggle with cancer.
Despite all the money and effort we've spent to battle cancer over the years (the U.S. government spends about $5 billion annually on cancer research), we've made little progress in overcoming cancer's lethal power.
Today, we again address one of our most divisive topics... the dangers of heartburn drugs.
Every time we talk about heartburn medication, we get a flood of messages from readers.
A couple weeks ago, we asked if you wanted us to continue writing about health topics or stick to finance.
The response was overwhelming... within hours we received hundreds of e-mails from subscribers asking us to continue sharing our research on health topics.
I'm a skeptic.
I'm constantly traveling the globe in search of new information and experts in various fields. Even if someone is an "expert" on a topic, I'm not afraid to question him. I even encourage my team to question me...
This week, a reader wrote in suggesting we should "stick to finance" because there are plenty of other health newsletters on the market.
He's right, there are other health letters out there. I would know... I read a lot of them.
When I got to Wall Street, I already thought I was a hotshot.
In college, I had read Barron's and other financial newsletters. I wasn't like the other new recruits who rarely turned past the sports page.
From navigating the "Trump Bump" to an "in person" interview with Thomas Jefferson, it's been quite a ride…
This week I'm in Vegas for the annual Stansberry Conference and Alliance Meeting. It's a gathering of the best folks in financial research. We've had presentations from Shark Tank investor Kevin O'Leary, political satirist P. J. O'Rourke, Senior Editor of Digital Products at The Economist Kenneth Cukier, and of course a range of our own talented analysts from Stansberry Research.
I just made one of the biggest calls of my career.
The first came in 2010, when I realized we were in the early stages of a meaningful bull market. But money was being left on the table.
You've flooded our inbox with health questions this week... from acid ingestion to meditation.
So today, we're sending a special "all health" edition of our weekly Q&A to answer some of your questions.
Our desks are an absolute mess.
Anyone who knows me knows that I have a cluttered desk. And my researcher is no different. Take a look at her reading pile: